Delivery Order SPE2DB24D1205-SPE2DB25FCZAQ
- Not listed
- The Defense Logistics Agency awarded a $22,765.02 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-unit quantity) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded transaction. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $12,110.70, with an ultimate completion date of June 2, 2025. This non-set-aside competitive award represents a single delivery order issued against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00...
- The Defense Logistics Agency awarded a $25,993.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of July 30, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $30,399.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a $11,072.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award was issued to the vendor's Corporate Office location in Conshohocken, Pennsylvania, supporting federal pharmaceutical procurement needs for military and veteran healthcare systems. The delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $25,380.07 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price contract type. The award was competitively procured with no set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's existing Indefinite...
- The Defense Logistics Agency awarded a $87,284.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of September 3, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $15,593.79 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg tablets, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $37,925.93 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 3, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary operations. This delivery order...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZAQDelivery Order
The Defense Logistics Agency awarded a $22,683.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of July 30, 2025. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical supply vehicle for military and federal healthcare systems. The place of performance is located at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's medical supply chain, fulfilling delivery orders across a comprehensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies. This delivery order for Eliquis, an anticoagulant medication, represents a routine transaction within the company's broader federal medical procurement responsibilities supporting military healthcare programs and other government health systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.7k | 7/29/25 |